Blastomycosis Treatment Market Size & Share, by Anatomy (Lung, Bones, Central Nervous System); Treatment {Medication (Itraconazole, Amphotericin B), Surgery}; End-user (Hospital, Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3667
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Companies Dominating the Blastomycosis Treatment Landscape

top-features-companies
    • Emcure Pharmaceuticals Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Viatris Inc.
    • Hindustan Antibiotics Limited
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  •  Viatris Inc. acquired Oyster Point Pharma and Famy Life Sciences, to establish a franchise for ophthalmology.

  • Sun Pharmaceutical Industries Ltd. obtained US FDA clearance for Amphotericin B injection. Further, Amphotericin B is an antifungal drug used to treat leishmaniasis and severe fungal infections, such as mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3667
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing population of immunocompromised patients and the rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Diagnoses of blastomycosis can be challenging, and exorbitant cost of treatment are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Viatris Inc., Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, anatomy, end user, and by region.

The medication segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying